(Q48968409)

17 February 2018

title

Integrity of the blood-cerebrospinal fluid barrier in early Parkinson's disease. (English)

1 reference

17 February 2018

blood-cerebrospinal fluid barrier

0 references

1 reference

1 reference

Haussermann P

1

1 reference

17 February 2018

Kuhn W

series ordinal

2

1 reference

17 February 2018

Przuntek H

series ordinal

3

1 reference

17 February 2018

Muller T

series ordinal

4

1 reference

17 February 2018

language of work or name

English

0 references

publication date

1 March 2001

1 reference

17 February 2018

published in

Neuroscience Letters

1 reference

17 February 2018

volume

300

1 reference

17 February 2018

page(s)

182-184

1 reference

17 February 2018

issue

3

1 reference

17 February 2018

Interleukin-1 beta and interleukin-6 are elevated in the cerebrospinal fluid of Alzheimer's and de novo Parkinson's disease patients.

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2801%2901574-9

7 January 2021

Immunocytochemical analysis of tumor necrosis factor and its receptors in Parkinson's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2801%2901574-9

7 January 2021

https://api.crossref.org/works/10.1016%2FS0304-3940%2801%2901574-9

1 reference

7 January 2021

Integrity of the blood-CSF barrier in dementia of Alzheimer type: CSF/serum ratios of albumin and IgG.

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2801%2901574-9

7 January 2021

Blood-cerebrospinal fluid barrier dysfunction for high molecular weight proteins in Alzheimer disease and major depression: indication for disease subsets.

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2801%2901574-9

7 January 2021

Glial cells and inflammation in Parkinson's disease: a role in neurodegeneration?

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2801%2901574-9

7 January 2021

Parkinsonism: onset, progression, and mortality

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2801%2901574-9

7 January 2021

Alcohol consumption and blood-cerebrospinal fluid barrier dysfunction in man.

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2801%2901574-9

7 January 2021

Oligoclonal bands in cerebrospinal fluid: a comparative study of isoelectric focusing, agarose gel electrophoresis and IgG index

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2801%2901574-9

7 January 2021

Decreased cerebrospinal fluid levels of neutral and basic amino acids in patients with Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2801%2901574-9

7 January 2021

Protein transfer at the blood cerebrospinal fluid barrier and the quantitation of the humoral immune response within the central nervous system.

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2801%2901574-9

7 January 2021

Barrier mechanisms in the brain, I. Adult brain.

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2801%2901574-9

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2801%2901574-9

7 January 2021

A population study on blood-brain barrier function in 85-year-olds: relation to Alzheimer's disease and vascular dementia.

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2801%2901574-9

7 January 2021

10.1016/S0304-3940(01)01574-9

Identifiers

DOI

1 reference

17 February 2018

PubMed ID

11226641

1 reference

17 February 2018